Advertisement

Die Alzheimer Demenz - ein Problem mit Zukunft

  • Hans Förstl
Conference paper

Zusammenfassung

Mit der Alzheimer Demenz (AD) müssen wir heute und - aufgrund der steigenden Lebenserwartung - noch stärker in der Zukunft rechnen, mit den individuellen Schicksalen der Patienten ebenso wie mit der wirtschaftlichen Belastung (Souetre et al. , 1999). Wenn in allen anderen Bereichen der Medizin weiterhin so erfreuliche Fortschritte erzielt werden, so kann gerade dies zu einer Zunahme der Patienten mit „primär degenerativer“AD führen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albert E (1963) Senile Demenz und Alzheimer - die gleiche Krankheit? Zbl Ges Neurol Psychiat 172: 264Google Scholar
  2. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat 64: 146Google Scholar
  3. Bertram L, Busch R, Spiegl et al. (1988) Paternal age as a risk factor for Alzheimer disease in the absence of a major gene. Neurogenetics 1: 277–280CrossRefGoogle Scholar
  4. Bobinski M, de Leon M, Convit A et al. (1999) MRI of entorhinal cortex in mild Alzheimers disease. Lancet 1: 38–39CrossRefGoogle Scholar
  5. Bowler JV, Munoz DG, Merskey H, Hachinski V (1998) Fallacies in the pathological confirmation of the diagnosis of Alzheimers disease. J Neurol Neurosurg Psychiatry 64: 18–24PubMedCrossRefGoogle Scholar
  6. Desgranges B, Baron JC, Sayette V de la et al. (1998) The neural substrates of memory systems impairment in Alzheimers disease. A PET study of resting brain glucose utilization. Brain 121: 611–631PubMedCrossRefGoogle Scholar
  7. Erkinjuntti T, Østbye T, Steenhuis R et al. (1997) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337 (23): 1667–1674PubMedCrossRefGoogle Scholar
  8. Fabrigoule C, Roüch I, Taberly A et al. (1998) Cognitive process in preclinical phase of dementia. Brain 121: 135–141PubMedCrossRefGoogle Scholar
  9. Förstl H (1998) Alzheimers disease: the size of the problem, clinical manifestation and heterogeneity. J Neural Transm Suppl 54: 1–8PubMedGoogle Scholar
  10. Förstl H, Jablenski (1999) Organisch bedingte psychische Störungen. Psychiatrie der Gegenwart. Bd. IV. Springer Berlin Heidelberg New York. pp. 1–12Google Scholar
  11. Förstl H, Zerfass R, Geiger-Kabisch C et al. (1995) Brain atrophy in normal ageing and Alzheimers disease : Volumetrie discrimination and clinical correlations. Brit J Psychiat 167: 739–746PubMedCrossRefGoogle Scholar
  12. Fox NC, Warrington EK, Seiffer AL et al. (1998) Presymptomatic cognitive deficits in individuals at risk of familial Alzheimers disease. A longitudinal study. Brain 121: 1631–1639PubMedCrossRefGoogle Scholar
  13. Henon H, Pasquier F, Durieu I et al (1998) Medial temporal lobe atrophy in stroke patients: relation to preexisting dementia. J Neurol Neurosurg Psychiatry 65: 641–647PubMedCrossRefGoogle Scholar
  14. Hodges J (1998) The amnestic prodrome of Alzheimer’s disease. Editorial. Brain: 1601-1602Google Scholar
  15. Holmes C, Cairns N, Lantos P, Mann A (1998) Validity of current clinical criteria for Alzheimers disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174: 45–50CrossRefGoogle Scholar
  16. Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095–1097PubMedCrossRefGoogle Scholar
  17. Kraepelin E (1910) Psychiatrie - ein Lehrbuch für Studierende und Ärzte. VIII. Aufl, Bd II, 1. Barth, LeipzigGoogle Scholar
  18. Kurz A, Riemenschneider M, Buch K et al. (1998) Tau cerebrospinal fluid is signifkantly increased at the earliest clinical stage of Alzheimer disease. Alz Dis Assoc Dis 12: 372–377CrossRefGoogle Scholar
  19. Lauter H, Meyer JE (1968) Clinical and nosological concepts of senile dementia. In: Müller, Ciompi (eds) Senile Dementia. Hans Huber, Bern Stuttgart, pp 13–26Google Scholar
  20. Masters CL, Beyreuther K (1998) Alzheimer’ disease. Science, medicine and the future. Brit Med J 316: 446–448PubMedCrossRefGoogle Scholar
  21. Minoshima S, Giordani B, Berent S et al. (1997) Metabolie Reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 42 (1): 85–94PubMedCrossRefGoogle Scholar
  22. Reiman EM, Uecker A, Caselli RJ et al. (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer’s disease. Ann Neurol 44 (2): 288–291PubMedCrossRefGoogle Scholar
  23. Snowdon DA, Greiner LH, Mortimer JA et al. (1997) Brain infaretion and the clinical expression of Alzheimer disease. The nun study. JAMA 277 (10): 813–817PubMedCrossRefGoogle Scholar
  24. Snowdon DA, Kemper SJ, Mortimer JA et al. (1996) Linguistic ability in early life and cognitive funetion and Alzheimer’s disease in late life. Findings from the nun study. JAMA 275 (7) 528–532PubMedCrossRefGoogle Scholar
  25. Stewart R (1998) Cardiovascular factors in Alzheimer’s disease. J Neurol Neurosurg Psychiat 65: 143–147PubMedCrossRefGoogle Scholar
  26. Souetre E, Thwaites RMA, Yeardley HL (1999) Economic impact of Alzheimer’s disease in the United Kingdom. Br J Psychiatry 174: 51–55PubMedCrossRefGoogle Scholar
  27. Troncoso JC, Cataldo AM, Nixon RA et al. (1998) Neuropathology of preclinical and clinical late-onset Alzheimer’s disease. Ann Neurol 43 (5): 673–676PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Hans Förstl

There are no affiliations available

Personalised recommendations